These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18082375)

  • 21. Flow cytometric assessment of susceptibilities of Streptococcus pyogenes to erythromycin and rokitamycin.
    Braga PC; Bovio C; Culici M; Dal Sasso M
    Antimicrob Agents Chemother; 2003 Jan; 47(1):408-12. PubMed ID: 12499226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both penicillin and amoxycillin should be tested in antimicrobial surveillance for Streptococcus pneumoniae.
    Garau J
    Clin Microbiol Infect; 2005 May; 11(5):422-3. PubMed ID: 15819875
    [No Abstract]   [Full Text] [Related]  

  • 23. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Yokota S; Ohkoshi Y; Fujii N
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin.
    Billal DS; Hotomi M; Yan SS; Fedorko DP; Shimada J; Fujihara K; Yamanaka N
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):225-8. PubMed ID: 19345038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors that cause trimethoprim resistance in Streptococcus pyogenes.
    Bergmann R; van der Linden M; Chhatwal GS; Nitsche-Schmitz DP
    Antimicrob Agents Chemother; 2014; 58(4):2281-8. PubMed ID: 24492367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
    Le Hello S; Page S; Garin B
    Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
    [No Abstract]   [Full Text] [Related]  

  • 27. Additional congeners of the macrolide neaumycin: structure revision and biological activity.
    Simone M; Maffioli SI; Tocchetti A; Tretter S; Cattaneo M; Biunno I; Gaspari E; Donadio S
    J Antibiot (Tokyo); 2015 Jun; 68(6):406-8. PubMed ID: 25586025
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
    Morrissey I; Maher K; Hawser S
    J Antimicrob Chemother; 2009 Feb; 63(2):413-4. PubMed ID: 19059943
    [No Abstract]   [Full Text] [Related]  

  • 29. [Synergistic effect of trimethoprim and sulfamethoxazole on staphylococci, group A streptococci and displococcus pneumoniae].
    Cybulska J; Zak C; Jeljaszewicz J
    Med Dosw Mikrobiol; 1971; 23(2):117-21. PubMed ID: 4398192
    [No Abstract]   [Full Text] [Related]  

  • 30. [Microbiological and chemotherapeutic study of the antibiotic mutabilicin].
    Perrova MA; Shneerson AN; Tebiakina AE; Navashin SM; Braginskaia PS
    Antibiotiki; 1967 May; 12(5):404-6. PubMed ID: 4385808
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
    Gracia M; Díaz C; Coronel P; Gimeno M; García-Rodas R; Rodríguez-Cerrato V; del Prado G; Huelves L; Ruiz V; Naves PF; Ponte MC; Granizo JJ; Soriano F
    Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group A streptococcal pharyngitis and penicillin G.
    Stollerman GH
    Clin Infect Dis; 2007 Mar; 44(5):763; author reply 763-4. PubMed ID: 17278078
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased resistance of Streptococcus pneumoniae isolates to antimicrobial drugs, at a referral hospital in north-west Ethiopia.
    Erqou S; Kebede Y; Mulu A
    Trop Doct; 2008 Apr; 38(2):110-2. PubMed ID: 18453508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro comparative study of Lidaprim and co-trimoxazole.
    Abdel-Messih EF; Suleiman MN; Baron JM
    J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study.
    Zafar A; Hussain Z; Lomama E; Sibille S; Irfan S; Khan E
    J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The drug susceptibility of penicillin-resistant Streptococcus pneumoniae].
    Koiuszko S; Białucha A; Gospodarek E
    Med Dosw Mikrobiol; 2007; 59(4):293-300. PubMed ID: 18416121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae.
    Leuthner KD; Cheung CM; Rybak MJ
    Antimicrob Agents Chemother; 2006 Feb; 50(2):813-6. PubMed ID: 16436754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combined actions of saliva, human amylase and antibiotics on Streptococcus pyogenes and Streptococcus agalactiae.
    Rotimi VO; Eke PI
    East Afr Med J; 1985 Apr; 62(4):236-42. PubMed ID: 2412781
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical microbiology of lincomycin antibiotics].
    Modde H
    Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
    [No Abstract]   [Full Text] [Related]  

  • 40. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.